VBI Vaccines
VBIV
#10524
Rank
NZ$3.25 M
Marketcap
NZ$0.11
Share price
0.00%
Change (1 day)
-89.56%
Change (1 year)

EPS for VBI Vaccines (VBIV)

EPS in 2024 (TTM): NZ-$16.49

According to VBI Vaccines 's latest financial reports the company's current EPS (TTM) is NZ-$17.60. In 2022 the company made an earnings per share (EPS) of NZ-$22.91 a decrease over its 2021 EPS that were of NZ-$14.06.

EPS history for VBI Vaccines from 1997 to 2024

Annual EPS

Year EPS Change
2024 (TTM)NZ-$16.49
2022NZ-$22.9162.96%
2021NZ-$14.0628.57%
2020NZ-$10.93-54.35%
2019NZ-$23.95-52.58%
2018NZ-$50.5010.23%
2017NZ-$45.8214.29%
2016NZ-$40.09-62.8%
2015NZ-$107.7790.68%
2014NZ-$56.52-7.95%
2013NZ-$61.41-57.97%
2012NZ-$146.12-78%
2011NZ-$664.273151.47%
2010NZ-$20.4323.87%
2009NZ-$16.49-18.48%
2008NZ-$20.2312.08%
2007NZ-$18.05-49.47%
2006NZ-$35.73
2005N/A-100%
2004NZ-$15.8811.94%
2003NZ-$14.19-81.89%
2002NZ-$78.35196.44%
2001NZ-$26.4384.33%
2000NZ-$14.34-65.37%
1999NZ-$41.40-29.45%
1998NZ-$58.6929.61%
1997NZ-$45.28

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
NZ-$1.65-90.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
NZ-$7.51-57.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
NZ-$6.37-63.81%๐Ÿ‡บ๐Ÿ‡ธ USA